ArticlePilot and feasibility studies2023

Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol.

Nadeeka Dissanayaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.